EUVIMEDEUVIMED entdecken
Crossref

Knockdown of LINC00853 Inhibits the Progression and Immune Escape of Hepatocellular Carcinoma by Targeting the miR‐16‐5p/PD‐L1 Axis

Dong Wang, Fei Zhao, Lei Wang, Shaocong Yan iD

Journal of Biochemical and Molecular Toxicology · 2026-05 · 40 (5)

DOI: 10.1002/jbt.70831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 22.04.2026. Verfasst von Dong Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Wuh…. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Clinical Key Specialty of General Surgery of Xiaoming Wang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non‐coding RNAs (lncRNAs) play crucial roles in hepatocellular carcinoma (HCC), offering valuable insights for therapeutic development. However, the clinical significance and functional mechanisms of LINC00853 in HCC remain poorly understood. This study aimed to evaluate the prognostic value of LINC00853 in HCC patients, and to investigate its underlying mechanisms in regulating HCC. A cohort of 123 HCC patients was enrolled in this study. LINC00853 expression in tumor tissues was quantified by quantitative reverse transcription‐PCR (qRT‐PCR). Prognostic significance of LINC00853 was assessed using Kaplan–Meier curves and Cox regression models. In vitro functional assays, including Cell Counting Kit‐8 (CCK‐8) and Transwell assays, were conducted to evaluate the effects of LINC00853 knockdown on cell proliferation, migration, and invasion. The regulatory axis involving LINC00853, miR‐16‐5p, and programmed death‐ligand 1 (PD‐L1) was validated by dual‐luciferase reporter assays. The role of LINC00853 in immune escape was investigated by co‐culturing CD8+ T cells with HCC cells and measuring cytotoxic activity along with cytokine (TNF‐α, IFN‐γ, IL‐10, and TGF‐β) levels. LINC00853 was significantly overexpressed in HCC tissues and was associated with unfavorable prognosis. Silencing LINC00853 suppressed the proliferation, migration, and invasion of HCC cells. Mechanistically, LINC00853 functioned as a molecular sponge for miR‐16‐5p, thereby upregulating PD‐L1 expression. In the co‐culture system, LINC00853 knockdown enhanced CD8+ T cell cytotoxicity and promoted the secretion of inflammatory cytokines (TNF‐α and IFN‐γ), while reducing immunosuppressive factors (IL‐10 and TGF‐β). These effects were reversed by the miR‐16‐5p inhibitor. LINC00853 may serve as a novel prognostic marker for HCC. Knockdown of LINC00853 suppresses the progression and immune escape by targeting the miR‐16‐5p/PD‐L1 axis, suggesting its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, HepatocellularLiver NeoplasmsRNA, Long NoncodingB7-H1 AntigenGene Knockdown TechniquesTumor EscapeRNA, NeoplasmHumansFemaleMaleDisease ProgressionCell ProliferationMiddle AgedCell Line, TumorGene Expression Regulation, NeoplasticCell Movement

Stichwörter der Autor:innen

LINC00853PD‐L1hepatocellular carcinomaimmune escapemiR‐16‐5p

Substanzen

MicroRNAsRNA, Long NoncodingB7-H1 AntigenMIRN16 microRNA, humanCD274 protein, humanRNA, Neoplasm

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Wuhu, Anhui, China.
  • Department of Traditional Chinese Medicine, Shandong First Medical University, Jinan, Shandong, China.
  • Department of Oncology, The First People's Hospital of Jingdezhen, Jingdezhen, Jiangxi, China.

ORCID-Profile: Shaocong Yan

Förderung

  • National Clinical Key Specialty of General Surgery of Xiaoming Wang

Zitieren

APA

Wang, D., Zhao, F., Wang, L., & Yan, S. (2026). Knockdown of LINC00853 Inhibits the Progression and Immune Escape of Hepatocellular Carcinoma by Targeting the miR‐16‐5p/PD‐L1 Axis. Journal of Biochemical and Molecular Toxicology, 40(5). https://doi.org/10.1002/jbt.70831

Vancouver

Wang D, Zhao F, Wang L, Yan S. Knockdown of LINC00853 Inhibits the Progression and Immune Escape of Hepatocellular Carcinoma by Targeting the miR‐16‐5p/PD‐L1 Axis. Journal of Biochemical and Molecular Toxicology. 2026;40(5). doi:10.1002/jbt.70831

BibTeX
@article{Wang2026,
  author = {Wang, Dong and Zhao, Fei and Wang, Lei and Yan, Shaocong},
  title = {Knockdown of LINC00853 Inhibits the Progression and Immune Escape of Hepatocellular Carcinoma by Targeting the miR‐16‐5p/PD‐L1 Axis},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  volume = {40},
  number = {5},
  doi = {10.1002/jbt.70831}
}
Kostenlos starten →